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Background: The aim of this study was to identify the predictive value of preprocedural glycosylated hemoglobin (HbA1C) level for cardiac events 
during short term follow-up period in diabetic patients complicated by AMI.
Background: The optimal HbA1C level in diabetic patients remained to be controversial era, but may be especially important in predicting the 
prognosis of diabetic patients with acute myocardial infarction (AMI).
Methods: A total of 1,411 AMI patients enrolled in a nationwide prospective Korea Working Group on Myocardial Infarction (KorMI) between Jan. 
2008 and Jan. 2009 were included in the present study. The study population were diabetic patients complicated by AMI and followed up during 
6 months period. They were categorized into two groups by the level of preprocedural HbA1C (Group I: >7%, n=859; Group II: ≤7%, n=552). Major 
adverse cardiac events (MACE) included cardiac death, non-cardiac death, re-myocardial infarction, coronary artery bypass graft, re-percutaneous 
coronary intervention.
Results: Baseline clinical characteristics were similar between two groups, but group I were younger (63.3±11.4 vs. 67.6±11.0, p<0.001). 
Laboratory findings showed higher glomerular filtration rate (GFR) (72.3±35.8mL/min vs. 64.5±34.3mL/min, p<0.001) and LDL-cholesterol level 
(111.8±40.9mg/dL vs. 105.6±42.6mg/dL, p=0.004). Coronary angiographic findings showed no meaningful difference except more frequent 
involvement of left anterior descending artery in group I (48.4% vs. 41.9%, p=0.026). In-hospital mortality and rates of MACEs during 6 months were 
similar between two groups (5.0% vs. 5.8%, p=0.55; 11.2% vs. 9.2%, p=0.49, respectively). By multivariate analysis, old age, low GFR, high Killip 
class on admission were independently associated with MACEs, but HbA1C was not associated with poor patient outcome during short term follow-
up period.
Conclusion: This study suggested that HbA1C is not a predictor of cardiac events in diabetic patients with AMI. These results suggest the absence 
of benefit of a strict hyperglycemia control in macrovascular complications, especially coronary artery disease such as myocardial infarction.
